Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predatory Invitations from Journals: More Than Just a Nuisance?
Clemons M, de Costa E Silva M, Joy AA, Cobey KD, Mazzarello S, Stober C, Hutton B. Clemons M, et al. Among authors: mazzarello s. Oncologist. 2017 Feb;22(2):236-240. doi: 10.1634/theoncologist.2016-0371. Epub 2017 Feb 10. Oncologist. 2017. PMID: 28188258 Free PMC article.
Surviving Surveys.
Mazzarello S, Clemons M, Graham ID, Jacobs C. Mazzarello S, et al. J Oncol Pract. 2015 Jan;11(1):44-6. doi: 10.1200/JOP.2014.001484. Epub 2014 Aug 5. J Oncol Pract. 2015. PMID: 25095823 No abstract available.
Dosing Strategies of Bone-Targeting Agents.
Hutton B, Mazzarello S, Clemons M. Hutton B, et al. Among authors: mazzarello s. JAMA Intern Med. 2015 Nov;175(11):1864-5. doi: 10.1001/jamainternmed.2015.4789. JAMA Intern Med. 2015. PMID: 26524744 No abstract available.
Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer: a systematic review.
Fernandes R, Mazzarello S, Stober C, Vandermeer L, Dudani S, Ibrahim MF, Majeed H, Perdrizet K, Shorr R, Hutton B, Fergusson D, Clemons M. Fernandes R, et al. Among authors: mazzarello s. Breast Cancer Res Treat. 2017 Jan;161(1):1-10. doi: 10.1007/s10549-016-4028-0. Epub 2016 Oct 25. Breast Cancer Res Treat. 2017. PMID: 27783280 Review.
A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage breast cancer.
Ibrahim MFK, Hilton J, Mazzarello S, Fergusson D, Hutton B, Robinson A, Califaretti N, Hsu T, Gertler S, Mates M, Stober C, Vandermeer L, Mallick R, Clemons M. Ibrahim MFK, et al. Among authors: mazzarello s. Breast Cancer Res Treat. 2018 Apr;168(2):371-379. doi: 10.1007/s10549-017-4604-y. Epub 2017 Dec 6. Breast Cancer Res Treat. 2018. PMID: 29214415 Clinical Trial.
70 results